INNOVATE BIOPHARMACEUTICALS, INC - 48 Year Dividend Yield History | INNT
Historical dividend payout and yield for INNOVATE BIOPHARMACEUTICALS, INC (INNT) since 1971. The current TTM dividend payout for INNOVATE BIOPHARMACEUTICALS, INC (INNT) as of February 20, 2019 is $0.00. The current dividend yield for INNOVATE BIOPHARMACEUTICALS, INC as of February 20, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.